MAST4
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| microtubule associated serine/threonine kinase family member 4 | MIM:618002 | Ensembl:ENSG00000069020 | HGNC:HGNC:19037 | PA134920494 | 5q12.3 |
GO terms in MAST4
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| CC | IEA | GO:0005737 | cytoplasm |
| BP | IBA | GO:0007010 | cytoskeleton organization |
| BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | IBA | GO:0035556 | intracellular signal transduction |
| MF | IEA | GO:0000287 | magnesium ion binding |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: MAST4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MAST4
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD221 | Tamoxifen | 3 |
| iGMDRD289 | Parthenolide | 2 |
| iGMDRD434 | BMS-536924 | 1 |
| iGMDRD267 | Oligomycin A | 3 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD220 | fumonisin B1 | 2 |
| iGMDRD137 | Indisulam | 3 |
| iGMDRD158 | NSC141540 | 3 |
| iGMDRD121 | GMX1778 | 7 |
| iGMDRD5 | Tyrphostin AG 1478 | 1 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD505 | Pevonedistat | 2 |
| iGMDRD300 | Tozasertib | 1 |
| iGMDRD246 | NPC26 | 2 |
| iGMDRD534 | BRD1429 | 1 |
| iGMDRD322 | FK 866 | 3 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD871 | BRD6368 | 6 |
| iGMDRD872 | BRD7137 | 6 |
| iGMDRD662 | JQ-1 | 3 |
| iGMDRD150 | RITA | 6 |
| iGMDRD560 | MK-2206 | 3 |
| iGMDRD116 | CD437 | 2 |
| iGMDRD424 | Tamatinib | 1 |
| iGMDRD84 | Lovastatin acid | 3 |
| iGMDRD330 | BRD4132 | 1 |
| iGMDRD512 | nutlin 3 | 2 |
| iGMDRD945 | ML214 | 1 |
| iGMDRD511 | CHEMBL399379 | 2 |
| iGMDRD85 | Ursolic acid | 1 |
| iGMDRD57 | Chloropentafluorobenzene | 3 |
| iGMDRD318 | PAC-1 | 5 |
| iGMDRD441 | TW 37 | 1 |
| iGMDRD187 | BRD9876 | 2 |
| iGMDRD247 | Blebbistatin | 1 |
| iGMDRD474 | Avrainvillamide | 1 |
| iGMDRD255 | SB225002 | 1 |
| iGMDRD369 | TGX-115 | 3 |
| iGMDRD356 | PNU-74654 | 5 |
| iGMDRD268 | Cerulenin | 3 |
| iGMDRD23 | Gossypol | 2 |
| iGMDRD100 | Zebularine | 4 |
| iGMDRD188 | Piperlongumine | 6 |
| iGMDRD887 | Compound 23 citrate | 2 |
| iGMDRD730 | Kahalalide F | 3 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD126 | Tipifarnib | 5 |
| iGMDRD151 | CHM-1 | 1 |
| iGMDRD387 | CHIR-99021 | 2 |
| iGMDRD1008 | SR-II-138A | 2 |
| iGMDRD420 | Leucascandrolide A | 1 |
| iGMDRD297 | Austocystin D | 3 |
| iGMDRD394 | BX-795 | 1 |
| iGMDRD375 | GW-405833 | 3 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD316 | N9-Isopropyl-olomoucine | 1 |
| iGMDRD639 | YK 4-279 | 2 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD163 | all trans Retinoic Acid | 1 |
| iGMDRD193 | Fqi1 | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MAST4
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.